Enlivex Ltd.

US$1.27As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ENLVHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (63.93%)
Div yield —
ROE 162.86%
Biotechnology
Beta (5Y) 1.61
PE TTM —
TSR TTM (99.50%)
Mkt cap US$1.580M
ROIC (0.64%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.57
23.88%
(97.20%)
Hold 9|4|4|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
(5.86%)
2.15%
10.68%
14.23%
Revenue$M
0.210
0.212
0.222
0.223
9.63%
11.52%
10.19%
9.80%
Peers (US$1.580M)
Cap (US$)
PE
2.854M
—
1.575M
—
Capital
TTM
5Y
10Y
Leveragex
1.097
0.896
0.683
EBIT/Intx
2.423
0.190
0.243
Own earn%
56.88
(96.59)
(84.25)
Sh yield%
26.99
30.54
30.72
Owners
Insiders/Inst%
3.63
86.85
Short interest%
5.51
SBC / revenue%
2.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
6–12
$1 testx
0.0
Incr. ROIC%
0